Cargando…
Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3
Osteoporosis is a debilitating skeletal disorder that is characterized by loss of bone density over time. It affects one in two women and one in four men, age 50 and older. New treatments that specifically drive bone formation are desperately needed. We developed a peptide, CK2.3, that acts downstre...
Autores principales: | Vrathasha, Vrathasha, Booksh, Karl, Duncan, Randall L., Nohe, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071089/ https://www.ncbi.nlm.nih.gov/pubmed/29987256 http://dx.doi.org/10.3390/nano8070513 |
Ejemplares similares
-
Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis
por: Vrathasha, Vrathasha, et al.
Publicado: (2019) -
Bone Morphogenetic Protein-2 Conjugated to Quantum Dot(®)s is Biologically Functional
por: Halloran, Daniel, et al.
Publicado: (2020) -
CK2.3, a Mimetic Peptide of the BMP Type I Receptor, Increases Activity in Osteoblasts over BMP2
por: Weidner, Hilary, et al.
Publicado: (2019) -
A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats
por: Sequeira, Linda, et al.
Publicado: (2020) -
Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice
por: Nguyen, John, et al.
Publicado: (2018)